Contract SPE2DS21F0078
Abbott Rapid Dx North America Llc · Department Of Defense · September 2, 2021
Abbott Rapid Dx North America Llc was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on September 2, 2021 for $51.00 million (current value) of work in in-vitro diagnostic substance manufacturing. Performance is in Orlando, FL. This is a task or delivery order issued under parent IDIQ SPE2DE21D0023. The contract has been modified 7 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 30, 2021. If all options are exercised, the contract could reach $51.00 million.
Contract details
- PIID
- SPE2DS21F0078
- Parent IDIQ
- SPE2DE21D0023
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Orlando, FL
- First action
- September 2, 2021
- Latest action
- September 30, 2021
Description
8508420509!BINAXNOWTEST KIT (EA)
Modification timeline
-
September 30, 2021Mod P00009 · Change Order$51.00M
-
September 29, 2021Mod P00008 · Change Order$51.00M
-
September 23, 2021Mod P00007 · Change Order$51.00M
-
September 16, 2021Mod P00006 · Change Order$51.00M
-
September 10, 2021Mod P00005 · Change Order$51.00M
-
September 9, 2021Mod P00003 · Change Order$51.00M
-
September 9, 2021Mod P00004 · Change Order$51.00M
-
September 2, 2021Mod P00002 · Change Order$51.00M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2DS21F0078?
Contract SPE2DS21F0078 is a federal contract awarded to Abbott Rapid Dx North America Llc by Department Of Defense on September 2, 2021 for $51.00 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 7 times since the base award.
Who won contract SPE2DS21F0078?
Abbott Rapid Dx North America Llc won contract SPE2DS21F0078 from Department Of Defense.
How much is contract SPE2DS21F0078 worth?
Contract SPE2DS21F0078 has obligated $0 to date but carries a potential ceiling of $51.00 million if fully funded and all options are exercised.